Joshua F. Patterson's Net Worth

$495 Thousand

Estimate Recalculated Sep 8, 2024 07:36PM EST

Who is Joshua F. Patterson?

Joshua F. Patterson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Gamida Cell Ltd., AKCEA THERAPEUTICS, INC., and CG Oncology, Inc..

SEC CIK

Joshua F. Patterson's CIK is 0001805702

Past Insider Trading and Trends

2020 was Joshua F. Patterson's most active year for acquiring shares with 3 total transactions. Joshua F. Patterson's most active month to acquire stocks was the month of December. 2020 was Joshua F. Patterson's most active year for disposing of shares, totalling 6 transactions. Joshua F. Patterson's most active month to dispose stocks was the month of September. 2024 saw Joshua F. Patterson paying a total of $0.00 for 580,319 shares, this is the most they've acquired in one year. In 2020 Joshua F. Patterson cashed out on 48,699 shares for a total of $550,936.96, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Gamida Cell Ltd. (GMDA) No price found

GENERAL COUNSEL

Joshua F. Patterson owns 855,461 units of Ordinary Shares.acquired a total of 594,319 shares in Gamida Cell Ltd..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+128.04%
480.32K
—
—
855.46K
Jan 31
Form 4
+77.78%
63K
—
—
144K
Feb 8
Form 4
+170.00%
51K
—
—
81K
Jan 28
Form 3
—
0
—
—
0
No matching records found

AKCEA THERAPEUTICS, INC. No price found

General Counsel

Joshua F. Patterson used to own units in Common Stock but no longer holds any shares there. In the year 2020 Joshua F. Patterson filed a total of 7 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-26.53K
$18.15
-$481,555.80
0
Oct 12
Form 4
-1.19%
-319.00
$18.12
-$5,780.28
26.53K
Sep 22
Form 4
-0.97%
-263.00
$12.50
-$3,287.79
26.85K
Jul 17
Form 4
+85.53%
12.5K
—
—
27.11K
Apr 15
Form 4
-2.24%
-335.00
$11.76
-$3,938.09
14.61K
Mar 23
Form 4
+33.84%
3.78K
—
—
14.95K
Mar 19
Form 3
—
0
—
—
0
No matching records found

CG Oncology, Inc. No price found

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 15
Form 3
—
0
—
—
0
No matching records found